Paul S. Uster
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
- Biomaterials 15
- Nanoparticle-Based Drug Delivery 14
-
- Advanced Fluorescence Microscopy Techniques 3
- Co-authors
- Kevin J. HarringtonJ.S.W. StewartA. M. PetersR G VileDavid W. DeamerS. MohammadtaghiDaphne M. GlassMary S. Newman
- Journals
- British Journal of Cancer (4 papers)International Journal of Cancer (4 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)International Journal of Pharmaceutics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Paul S. Uster
31 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 104
- Biomaterials 888
- Pharmaceutical Science 101
- Molecular Biology 958
- Radiology, Nuclear Medicine and Imaging 273
- Biomedical Engineering 514
Countries citing papers authored by Paul S. Uster
This map shows the geographic impact of Paul S. Uster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Uster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Uster more than expected).
Fields of papers citing papers by Paul S. Uster
This network shows the impact of papers produced by Paul S. Uster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Uster. The network helps show where Paul S. Uster may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul S. Uster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 22 | |
| 2 | 2004 | 11 | |
| 3 | 2002 | 3 | |
| 4 | 2001 | 11 | |
| 5 | 2001 | 11 | |
| 6 | 2000 | 74 | |
| 7 | 2000 | 76 | |
| 8 | 2000 | 26 | |
| 9 | 1999 | 40 | |
| 10 | 1999 | 35 | |
| 11 | 1998 | 1 | |
| 12 | Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts. | 1998 | 40 |
| 13 | 1997 | 89 | |
| 14 | 1996 | 249 | |
| 15 | 1996 | 18 | |
| 16 | 1995 | 63 | |
| 17 | 1995 | 1 | |
| 18 | 1993 | 8 | |
| 19 | 1993 | 57 | |
| 20 | 1989 | 60 |
About Paul S. Uster
Paul S. Uster is a scholar working on Biomaterials, Biophysics, Otorhinolaryngology, Pharmaceutical Science and Toxicology, having authored 31 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (10 papers), Lipid Membrane Structure and Behavior (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Advanced Fluorescence Microscopy Techniques (3 papers), Radiation Therapy and Dosimetry (3 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Biomaterials (888 citations), Pharmaceutical Science (101 citations), Molecular Biology (958 citations), Radiology, Nuclear Medicine and Imaging (273 citations) and Biomedical Engineering (514 citations). Paul S. Uster has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Kevin J. Harrington, J.S.W. Stewart, A. M. Peters, R G Vile, David W. Deamer, S. Mohammadtaghi, Daphne M. Glass, Mary S. Newman, Theresa M. Allen and Gail Rowlinson‐Busza. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, International Journal of Pharmaceutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.